Clinical Trials

Clinical trials are studies that are designed to test whether treatments are safe and effective at improving outcomes for patients.

Clinical trials are divided into different phases depending on the stage of drug development. The earlier phases (phase I and II) look at whether a drug is safe (e.g. to understand the side effects it causes) and whether it shows some signs of efficacy (e.g. a higher response rate than expected in the intended group of patients). Later phase III trials aim to test whether a new promising treatment is better than the best currently available treatments.

In this section, you will learn about the importance of clinical trials, where you can obtain more information on the on-going AML trials and what you can expect if you would like to be part of one. Many physicians will recommend at least discussing the trial opportunities available since it is a chance to receive the best standard of care in a top institute, where you will be very closely monitored.

If you have any questions or concerns, don’t hesitate to discuss these with your healthcare team, as well as contacting patient support groups. 

 

Videos

What’s the Follow-Up Plan After a Clinical Trial?

What happens after a patient participates in a clinical trial for cancer treatment? Watch now to hear both patient and expert perspectives on post-trial follow-up care.

Published:

How Can AML Patients Get Involved With Clinical Trials?

Even though U.S. clinical trial enrollment is very low, the trials bring development and new medicines to patients. Watch as Leah Szumita breaks down how patients can get involved.

Published:

Does the Clinical Trial Process Need an Extreme Makeover?

In this MythBusters program, patient advocate Jim Omel and Dr. Michael Thompson examine barriers patients may face and discuss the safety and quality of clinical trial care. Does the process need a makeover? Watch now to find out more.

Published:

Which AML Patients Should Consider a Clinical Trial?

Which AML patients should consider a clinical trial? Dr. Lee Greenberger shares the different response rate for patients under 60 and 60+, and approaches for finding the right treatment match.

Published:

Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on March 8, 2017